Loading...
Prognostic factors in potentially resectable stage III non-small cell lung cancer receiving neoadjuvant treatment—a narrative review
Lung cancer is the leading cause of cancer-related death in worldwide. The most important treatment for patients with stage I and II non-small cell lung cancer (NSCLC) is surgery. Resected stage II and III NSCLC patients should be offered adjuvant chemotherapy and in patients with resected stage IB...
Saved in:
| Published in: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
AME Publishing Company
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7867763/ https://ncbi.nlm.nih.gov/pubmed/33569338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-515 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|